NCT02771184

Brief Summary

This clinical trial is conducted within the research project 'Computerized Lung Sound Analysis'. The research goal is the development of a system enabling the automatic classification of lung sounds, which will result in a decision support system for physicians. The objective of this trial is to create a small lung sound corpus, enabling the development of a prototype of the described system. Therefore, investigators record lung sounds with several lung sound transducers distributed on the posterior chest of human test subjects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

April 22, 2016

Completed
21 days until next milestone

First Posted

Study publicly available on registry

May 13, 2016

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
Last Updated

May 20, 2019

Status Verified

May 1, 2019

Enrollment Period

1.9 years

First QC Date

April 22, 2016

Last Update Submit

May 16, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • 16-Channel Lung Sound Recordings and synchronous Airflow Recording

    The lung sounds and the airflow signal are simultaneously recorded with the Lung Sound Recording System. One time frame contains several breathing phases. Depending on the lung disease normal lung sounds are either altered or adventitious lung sounds are superimposed.

    30 Seconds

Study Arms (3)

Lung-Healthy

OTHER

Subjects with no diagnosed lung disease. The intervention is the recording of lung sounds with the Lung Sound Recording System.

Device: Lung Sound Recording System

Pneumothorax

OTHER

Subjects with pneumothorax. The intervention is the recording of lung sounds with the Lung Sound Recording System.

Device: Lung Sound Recording System

Pulmonary Fibrosis

OTHER

Subjects with pulmonary fibrosis. The intervention is the recording of lung sounds with the Lung Sound Recording System.

Device: Lung Sound Recording System

Interventions

The lung sounds are recorded over the posterior chest in supine position on an examination table. A foam pad with several lung sound transducers is placed under the back of the subjects. During the recording the subjects wear a nose clip and hold a pneumotachograph with both hands. The subjects are instructed to breath at a certain airflow rate during inspiration, with natural breathing during expiration. Therefore, they receive a real-time feedback for the airflow rate. The airflow signal and the lung sounds from 16 lung sound transducers are recorded simultaneously for 30 seconds.

Lung-HealthyPneumothoraxPulmonary Fibrosis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • General:
  • Smoker and non-smoker
  • 'Lung-healthy' subjects (control group), subjects with pneumothorax or subjects with pulmonary fibrosis
  • Additional for 'lung-healthy' subjects:
  • COPD \< 3 (GOLD Criteria)

You may not qualify if:

  • General:
  • Body Mass Index \> 30
  • Preceding thoracic surgery
  • Non-cooperation of the subject
  • Intubated or tracheostomized subjects
  • Additional for 'lung-healthy' subjects:
  • Disease of the respiratory system
  • Taking medication influencing the respiration

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Graz

Graz, 8010, Austria

Location

MeSH Terms

Conditions

PneumothoraxPulmonary Fibrosis

Condition Hierarchy (Ancestors)

Pleural DiseasesRespiratory Tract DiseasesLung Diseases, InterstitialLung DiseasesFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Freyja-Maria Smolle-Juettner, Univ.-Prof.

    Medical University of Graz

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Univ.-Prof. Dr.med.univ.

Study Record Dates

First Submitted

April 22, 2016

First Posted

May 13, 2016

Study Start

April 1, 2016

Primary Completion

March 1, 2018

Study Completion

March 1, 2018

Last Updated

May 20, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations